SterisCare's second manufacturing block, Block B, has been fully commissioned following an 18-month construction and qualification programme. The new block doubles our solid dosage production capacity, adding 2.4 billion tablets per annum to our existing output of 2.5 billion units.
Block B is built to current Good Manufacturing Practices (cGMP) standards with dedicated suites for high-potency active pharmaceutical ingredients (HPAPIs) and a state-of-the-art coating facility for modified-release formulations.
Technical Specifications
- Total floor area: 14,000 sq. metres across three floors.
- 6 independent granulation and compression suites.
- Dedicated HPAPI containment suite (OEB Level 4).
- Centralised building management system for real-time environmental monitoring.
The enhanced capacity enables us to meet growing institutional tender demand and fulfil our export commitments without compromise on lead times.
